Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C [5]

Inflammatory Bowel Diseases

Volumn 13, Issue 9, 2007, Pages 1189-1190

  Tursi, Antonio ^a  

^a Lorenzo Bonomo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BECLOMETASONE; INTERFERON; MACROGOL; MESALAZINE; PROBIOTIC AGENT; RIBAVIRIN;

ADULT; ANAMNESIS; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; COLON BIOPSY; COLONOSCOPY; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG DELIVERY SYSTEM; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER DISEASE; MALE; PRIORITY JOURNAL; THYROID DISEASE; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTIVIRAL AGENTS; CHRONIC DISEASE; COLITIS, ULCERATIVE; EDEMA; GENOTYPE; HEPATITIS C; HUMANS; IMMUNE SYSTEM; INTERFERON ALFA-2A; INTERFERONS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 34548628636     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20152     Document Type: Letter

References (10)

1. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother. 1999;53:242-254.
2. Mavrogiannis C, Papanikolau IS, Elefsiniotis IS, Psilopoulos DI, Karameris A, Karvountis G. Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol. 2001;34:964-965.
3. Awakawa T, Hirohashi S, Hasegawa K, et al. A case of acute phase ulcerative colitis like colitis developed by the interferon-beta therapy for chronic hepatitis C. Nippon Shokakibyo Gakkai Zasshi. 2003;100:680-684.
4. Bargiggia S, Thornburn D, Anderloni A, et al. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Aliment Pharmacol Ther. 2005;22:209-215.
5. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini. Onset of celiac disease during treatment with interferon for chronic hepatitis C. Lancet. 2000;356:1494-1495.
6. Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B. Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C. Gastroenterol Clin Biol. 2005;29:193-196.
7. Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ ribavirin treatment for chronic hepatitis. Gut. 2005;54:438-439.
8. Watanabe T, Inoue M, Harada K, et al. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon α-2b and ribavirin. Gut. 2006;55: 1682-1683.
9. Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and presenrves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol. 1998;160:3487-3493
10. Tursi A. Onset of Crohn's disease after Helicobacter pylori eradication. Inflamm Bowel Dis. 2006;12:1008-1009